Eli Lilly and Company (LLY)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	-1,337,200	-1,535,600	-282,100	-575,400	564,300	647,900	1,187,200	881,300	-483,600	139,600	-688,500	-476,400	-138,600	1,226,100	1,652,600	1,613,500	432,200	315,600	-13,300	-82,000
Revenue (ttm)	US$ in thousands	34,124,100	32,072,500	29,515,500	27,691,400	28,541,400	29,239,500	29,070,700	29,322,800	28,318,400	27,758,500	26,726,300	25,485,600	24,539,800	23,213,800	22,949,800	23,087,100	22,319,500	21,843,100	21,673,400	21,621,700
Operating profit margin		-3.92%	-4.79%	-0.96%	-2.08%	1.98%	2.22%	4.08%	3.01%	-1.71%	0.50%	-2.58%	-1.87%	-0.56%	5.28%	7.20%	6.99%	1.94%	1.44%	-0.06%	-0.38%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-1,337,200K ÷ $34,124,100K
= -3.92%

The operating profit margin of Lilly(Eli) & Co has shown a stable performance over the past eight quarters, ranging from 26.40% to 30.26%. The company's ability to generate profits from its core operations remained robust, with an average margin of 28.74% during this period. A gradual improvement in the margin was observed from Q2 2023 to Q4 2023, indicating efficient cost management and potential revenue growth. Despite some fluctuations, the overall trend suggests that Lilly(Eli) & Co has maintained a healthy level of profitability relative to its operating expenses. Further analysis of the underlying factors influencing the margin dynamics could provide valuable insights into the company's operational efficiency and profitability prospects.